Delivery Order SPE2DB20D7061-SPE2DB25FSPU7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,290.91 to AmerisourceBergen Drug Corp for Precedex 200 mcg/2 ml vials on July 14, 2025, with an ultimate completion date of July 15, 2025. This is a firm fixed-price contract with no set-aside designation, indicating competitive award through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Precedex (dexmedetomidine) is a sedative medication commonly used in...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to supply Precedex 80 mcg/20 ml vial, a critical care medication, for $2,160.08. The award is not set aside and has an ultimate completion date of August 8, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a comprehensive...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,163.07 to AmerisourceBergen Drug Corp for PRECEDEX 100 2ML 25S on August 28, 2025, with completion scheduled for August 29, 2025. This firm fixed-price delivery order represents a competitively awarded procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order from its corporate office...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,017.60 by the Defense Logistics Agency on September 5, 2025, for the supply of PRECEDEX 200 mcg/50 ml bottles. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 8, 2025, with performance taking place at the contractor's Conshohocken facility. The award represents a child...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,400.14 by the Medical Supply Chain on September 5, 2025. The contract calls for the delivery of dexmedetomidine 400 micrograms per 100 milliliters in a 100-milliliter saline solution package, with an ultimate completion date of September 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under open competition...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,009.28 to AmerisourceBergen Drug Corp on September 12, 2025, with an ultimate completion date of September 15, 2025. This is a firm fixed-price, non-set-aside delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion and extending through December 2026. The delivery order represents a small-value...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Dexmedetomidine 400 micrograms per 100 milliliters in normal saline solution (100 milliliters). The contract has a ceiling value of $11,209.75 and is structured as a firm fixed price delivery order with an ultimate completion date of May 21, 2025. This award was not designated as a set-aside contract, indicating it was competitively awarded. The place of performance is...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,474.82 to AmerisourceBergen Drug Corp on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The award was competitively...
- The Defense Logistics Agency Medical Supply Chain issued a delivery order valued at $2,411.18 to AmerisourceBergen Drug Corp on September 13, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,708.00 to AmerisourceBergen Drug Corp on September 10, 2025, with an ultimate completion date of September 11, 2025. This firm fixed-price delivery order, issued under contract number 4569424241, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation....
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB25FSPU7Delivery Order
The Defense Logistics Agency (DLA) awarded a $2,209.00 delivery order to AmerisourceBergen Drug Corp for Precedex 1,000 micrograms per 250 milliliter bags on September 17, 2025, with an ultimate completion date of September 18, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. This award represents a single transaction fulfilling federal medical supply requirements through AmerisourceBergen's established procurement vehicle. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen maintains an extensive portfolio of federal contract awards with DLA and the Defense Health Agency, demonstrating its capability to meet complex medical procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/17/25 |